[1] Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al . A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998 ; 54 ( 4 ): 315 − 21 .
[2] Van Puijenbroek EP, Diemont WL, Van Grootheest K . Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions. Drug Saf 2003 ; 26 ( 5 ): 293 − 301 .
[3] Van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG . A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002 ; 11 ( 1 ): 3 − 10 .
[4] Evans SJW, Waller PC, Davis S . Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001 ; 10 ( 6 ): 483 − 6 .
[5] Dumouchel W . Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999 ; 53 ( 3 ): 177 − 90 .
[6] Orre R, Lansner A, Bate A, Lindquist M . Bayesian neural networks with confidence estimations applied to data mining. Comput Stat Data Anal 2000 ; 34 ( 4 ): 473 − 93 .
[7] Deshpande G, Gogolak V, Smith SW . Data mining in drug safety: review of published threshold criteria for defining signals of disproportionate reporting. Pharm Med 2010 ; 24 ( 1 ): 37 − 43 .
[8] Cao LS, Yuan P . Thinking of China national immunization program information management system construction. Chin J Vaccines Immun 2010 ; 16 ( 6 ): 553 − 7 .
[9] Gu CM, Li Y, Wang BH. Real world data and evidence. Scientific and Technical Documentation Press. Beijing, 2022. (In Chinese).
[10] Li CJ. Researches on theory and application of adverse drug reaction signal detection [dissertation]. 2009. https://kns.cnki.net/kcms2/article/abstract?v=wcPNn8Zia7Ohp-UUl8oj7LKtjFIfAVpXcdzz9hIelBhHz7eLSkqvM37V14qbdr_zZW4zBKjpJLXt9iWOvmJCbSCZ26XThEsYhwGFVpqngeCT4LgnO12Aw8Npt6kIYa3j8RvfewILU8qL3XZB8jKlGQ==&uniplatform=NZKPT&language=CHS. [2023-03-18]. (In Chinese)
[11] Brown EG, Wood L, Wood S . The medical dictionary for regulatory activities (MedDRA). Drug Saf 1999 ; 20 ( 2 ): 109 − 17 .
[12] Candore G, Juhlin K, Manlik K, Thakrar B, Quarcoo N, Seabroke S, et al . Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug Saf 2015 ; 38 ( 6 ): 577 − 87 .
[13] Niu MT, Erwin DE, Braun MM . Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001 ; 19 ( 32 ): 4627 − 34 .
[14] Grunau G, Linn S . Commentary: sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health 2018 ; 6 : 256 .
[15] WHO. Global manual on surveillance of adverse events following immunization. Geneva: WHO; 2016. https://www.who.int/publications/i/item/9789241507769.
[16] Wu WD, Li KL, Zheng JS, Liu DW, Xu DS, Yang H, et al . Analysis on surveillance data of adverse events following immunization in China, 2011. Chin J Vaccines Immun 2013 ; 19 ( 2 ): 97 − 109 .
[17] Wu WD, Liu DW, Li KL, Zheng JS, Xu DS, Wang YM, et al . Analysis on surveillance data of adverse events following immunization in China, 2012. Chin J Vaccines Immun 2014 ; 20 ( 1 ): 1 − 12,66 .
[18] Ye JK, Li KL, Xu DS, Wu WD, Liu DW, Zheng JS, et al . Analysis of surveillance for adverse events following immunization in China, 2014. Chin J Vaccines Immun 2016 ; 22 ( 2 ): 125 − 37 .
[19] Ye JK, Li KL, Xu DS, Wu WD, Liu DW, Zheng JS, et al . Evaluation of the adverse events following immunization information management system in China, 2013. Chin J Vaccines Immun 2015 ; 21 ( 2 ): 121 − 31,200 .
[20] Ye JK, Li KL, Xu DS, Wu WD, Zheng JS, Cao L, et al . Surveillance of adverse events following immunization in China, 2015. Chin J Vaccines Immun 2017 ; 23 ( 5 ): 481 − 92,511 .
[21] Almenoff JS, LaCroix KK, Yuen NA, Fram D, DuMouchel W . Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. Drug Saf 2006 ; 29 ( 10 ): 875 − 87 .
[22] Kubota K, Koide D, Hirai T . Comparison of data mining methodologies using Japanese spontaneous reports. Pharmacoepidemiol Drug Saf 2004 ; 13 ( 6 ): 387 − 94 .
[23] Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, et al . The vaccine adverse event reporting system (VAERS). Vaccine 1994 ; 12 ( 6 ): 542 − 50 .
Baidu
map